Skip to main content
Top
Published in: Inflammation 2-3/2005

01-06-2005

Oral Temperature in Daily Life. A New Look in the Era of Microinflammation

Authors: O. Rogowski, I. Shapira, S. Toker, A. Shirom, S. Melamed, S. Berliner

Published in: Inflammation | Issue 2-3/2005

Login to get access

Abstract

It has been repeatedly shown that apparently healthy individuals and those with atherothrombotic risk factors harbor a low grade subclinical internal inflammation (microinflammation). This low grade acute phase response is relevant for the presence of atherothrombosis and future vascular events. Since these events are associated with a febrile response, we thought that it is relevant to clarify whether the microinflammatory response has an influence on the oral temperature. Included were 2,340 men and 1,280 women in whom the white blood cell count (WBCC) and differential, as well as the erythrocyte sedimentation rate (ESR), quantitative fibrinogen and high sensitivity C-reactive protein (hs-CRP) were determined in addition to the oral temperature in quiescent conditions. There was no association between these inflammatory biomarkers, except from a weak association with the absolute number of polymorphonuclear leukocytes. This association could be, however, related to the stress of the examination itself. Thus, it is unlikely that the microinflammatory response in daily life is associated, to a significant degree, with an enhanced oral temperature. The results are relevant for the findings of elevated oral temperature during conditions of acute ischemia/infarction where the temperature is probably related to the event itself and not to the patient's background microinflammation.
Literature
1.
go back to reference Viles-Gonzalez, J. F., V. Fuster, and J. J. Badimon. 2004. Atherothrombosis: a widespread disease with unpredictable and life-threatening consequences. Eur. Heart. J. 25:1197–1207.PubMedCrossRef Viles-Gonzalez, J. F., V. Fuster, and J. J. Badimon. 2004. Atherothrombosis: a widespread disease with unpredictable and life-threatening consequences. Eur. Heart. J. 25:1197–1207.PubMedCrossRef
2.
go back to reference Ridker P. M. 2003. Cardiology Patient Page. C-reactive protein: a simple test to help predict risk of heart attack and stroke. Circulation. 108:e81–e85.PubMedCrossRef Ridker P. M. 2003. Cardiology Patient Page. C-reactive protein: a simple test to help predict risk of heart attack and stroke. Circulation. 108:e81–e85.PubMedCrossRef
3.
go back to reference Libby P., and P. M. Ridker. 2004. Inflammation and atherosclerosis: role of C-reactive protein in risk assessment. Am. J. Med. 116:9S–16S.PubMedCrossRef Libby P., and P. M. Ridker. 2004. Inflammation and atherosclerosis: role of C-reactive protein in risk assessment. Am. J. Med. 116:9S–16S.PubMedCrossRef
4.
go back to reference Biasucci L. M. 2004. CDC/AHA workshop on markers of inflammation and cardiovascular disease: application to clinical and public health practice: clinical use of inflammatory markers in patients with cardiovascular diseases: a background paper. Circulation 110:e560–e567.PubMedCrossRef Biasucci L. M. 2004. CDC/AHA workshop on markers of inflammation and cardiovascular disease: application to clinical and public health practice: clinical use of inflammatory markers in patients with cardiovascular diseases: a background paper. Circulation 110:e560–e567.PubMedCrossRef
5.
go back to reference Hansson G. K. 2005. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352:1685–1695.PubMedCrossRef Hansson G. K. 2005. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352:1685–1695.PubMedCrossRef
6.
go back to reference Libby P., P. M. Ridker, and A. Maseri. 2002. Inflammation and atherosclerosis. Circulation 105:1135–1143.PubMedCrossRef Libby P., P. M. Ridker, and A. Maseri. 2002. Inflammation and atherosclerosis. Circulation 105:1135–1143.PubMedCrossRef
7.
go back to reference Ridker P. M. 2002. On evolutionary biology, inflammation, infection, and the causes of atherosclerosis. Circulation 105:2–4.PubMed Ridker P. M. 2002. On evolutionary biology, inflammation, infection, and the causes of atherosclerosis. Circulation 105:2–4.PubMed
9.
go back to reference Dinarello C. A. 1996. Thermoregulation and the pathogenesis of fever. Infect. Dis. Clin. North. Am. 10:433–449.PubMedCrossRef Dinarello C. A. 1996. Thermoregulation and the pathogenesis of fever. Infect. Dis. Clin. North. Am. 10:433–449.PubMedCrossRef
10.
go back to reference Bernheim H. A., L. H. Block, and E. Atkins. 1979. Fever: pathogenesis, pathophysiology, and purpose. Ann. Intern. Med. 91:261–270.PubMed Bernheim H. A., L. H. Block, and E. Atkins. 1979. Fever: pathogenesis, pathophysiology, and purpose. Ann. Intern. Med. 91:261–270.PubMed
11.
go back to reference Roy M. K., and A. Ray. 2004. Effect of body temperature on mortality of acute stroke. J. Assoc. Phys. India. 52:959–961. Roy M. K., and A. Ray. 2004. Effect of body temperature on mortality of acute stroke. J. Assoc. Phys. India. 52:959–961.
12.
go back to reference Rogowski O., S. Toker, I. Shapira, S. Melamed, A. Shirom, D. Zeltser, and S. Berliner. 2005. Values of high sensitivity C-reactive protein in each month of the year in apparently healthy individuals. Am. J. Cardiol. 95:152–155.PubMedCrossRef Rogowski O., S. Toker, I. Shapira, S. Melamed, A. Shirom, D. Zeltser, and S. Berliner. 2005. Values of high sensitivity C-reactive protein in each month of the year in apparently healthy individuals. Am. J. Cardiol. 95:152–155.PubMedCrossRef
13.
go back to reference Rogowski O., I. Shapira, A. Zimran, D. Zeltser, D. Elstein, D. Attias, A. Bashkin, and S. Berliner. 2005. Automated system to detect low-grade underlying inflammatory profile: Gaucher disease as a model. Blood Cells Mol. Diseases 34:26–29.CrossRef Rogowski O., I. Shapira, A. Zimran, D. Zeltser, D. Elstein, D. Attias, A. Bashkin, and S. Berliner. 2005. Automated system to detect low-grade underlying inflammatory profile: Gaucher disease as a model. Blood Cells Mol. Diseases 34:26–29.CrossRef
14.
go back to reference Berliner S., I. Shapira, S. Toker, S. Melamed, A. Shirom, and O. Rogowski. 2005. Benign hereditary leukopenia-neutropenia does not result from lack of low grade inflammation. A new look in the era of microinflammation. Blood Cells Mol. Diseases 34:135–140.CrossRef Berliner S., I. Shapira, S. Toker, S. Melamed, A. Shirom, and O. Rogowski. 2005. Benign hereditary leukopenia-neutropenia does not result from lack of low grade inflammation. A new look in the era of microinflammation. Blood Cells Mol. Diseases 34:135–140.CrossRef
15.
go back to reference Cohen S., T. Tolshinsky, O. Rogowski, I. Shapira, K. Lachmi, M. Hirsch, E. Ben Assayag, M. Burke, V. Deutch, S. Berliner, P. Halpern, and J. Serov. 2003. Real time, control adjusted evaluation of intensity of the inflammatory response. J. Inform. Techn. Healthcare 1:195–207. Cohen S., T. Tolshinsky, O. Rogowski, I. Shapira, K. Lachmi, M. Hirsch, E. Ben Assayag, M. Burke, V. Deutch, S. Berliner, P. Halpern, and J. Serov. 2003. Real time, control adjusted evaluation of intensity of the inflammatory response. J. Inform. Techn. Healthcare 1:195–207.
16.
go back to reference International committee for standardization in hematology. 1965. Recommendation of measurement of erythrocyte sedimentation rate of human blood. Immunochemistry 2:235–254.CrossRef International committee for standardization in hematology. 1965. Recommendation of measurement of erythrocyte sedimentation rate of human blood. Immunochemistry 2:235–254.CrossRef
17.
go back to reference Clauss A. 1957. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta. Haematol. Basel. 17:237–246.CrossRef Clauss A. 1957. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta. Haematol. Basel. 17:237–246.CrossRef
18.
go back to reference Rifai N., R. P. Tracy, and P. M. Ridker. 1999. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin. Chem. 45:2136–2141.PubMed Rifai N., R. P. Tracy, and P. M. Ridker. 1999. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin. Chem. 45:2136–2141.PubMed
19.
go back to reference Gabay C., and I. Kushner. 1999. Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 11:448–454.CrossRef Gabay C., and I. Kushner. 1999. Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 11:448–454.CrossRef
20.
go back to reference Kammersgaard L. P., H. S. Jorgensen, J. A. Rungby, J. Reith, H. Nakayama, U. J. Weber, J. Houth, and T. S. Olsen. 2002. Admission body temperature predicts long-term mortality after acute stroke: The Copenhagen Stroke Study. Stroke 33:1759–1762.PubMedCrossRef Kammersgaard L. P., H. S. Jorgensen, J. A. Rungby, J. Reith, H. Nakayama, U. J. Weber, J. Houth, and T. S. Olsen. 2002. Admission body temperature predicts long-term mortality after acute stroke: The Copenhagen Stroke Study. Stroke 33:1759–1762.PubMedCrossRef
21.
go back to reference Christensen H., G. Boysen, H. H. Johannesen, E. Christensen, and K. Bendtzen. 2002. Deteriorating ischaemic stroke. cytokines, soluble cytokine receptors, ferritin, systemic blood pressure, body temperature, blood glucose, diabetes, stroke severity, and CT infarction-volume as predictors of deteriorating ischaemic stroke. J. Neurol. Sci. 201:1–7.PubMedCrossRef Christensen H., G. Boysen, H. H. Johannesen, E. Christensen, and K. Bendtzen. 2002. Deteriorating ischaemic stroke. cytokines, soluble cytokine receptors, ferritin, systemic blood pressure, body temperature, blood glucose, diabetes, stroke severity, and CT infarction-volume as predictors of deteriorating ischaemic stroke. J. Neurol. Sci. 201:1–7.PubMedCrossRef
22.
go back to reference Castellanos M., R. Leira, J. Tejada, A. Gil-Peralta, A. Davalos, and J. Castillo. 2005. Predictors of good outcome in medium to large spontaneous supratentorial intracerebral haemorrhages. J. Neurol. Neurosurg. Psychiatry 76:691–695.PubMedCrossRef Castellanos M., R. Leira, J. Tejada, A. Gil-Peralta, A. Davalos, and J. Castillo. 2005. Predictors of good outcome in medium to large spontaneous supratentorial intracerebral haemorrhages. J. Neurol. Neurosurg. Psychiatry 76:691–695.PubMedCrossRef
23.
go back to reference Leira R., A. Davalos, Y. Silva, A. Gil-Peralta, J. Tejada, M. Garcia, and J. Castillo. 2004. Early neurologic deterioration in intracerebral hemorrhage: predictors and associated factors. Neurology 63:461–467.PubMed Leira R., A. Davalos, Y. Silva, A. Gil-Peralta, J. Tejada, M. Garcia, and J. Castillo. 2004. Early neurologic deterioration in intracerebral hemorrhage: predictors and associated factors. Neurology 63:461–467.PubMed
24.
go back to reference Nito C., T. Kamiya, M. Ueda, T. Arii, and Y. Katayama. 2004. Mild hypothermia enhances the neuroprotective effects of FK506 and expands its therapeutic window following transient focal ischemia in rats. Brain Res. 1008:179–185.PubMedCrossRef Nito C., T. Kamiya, M. Ueda, T. Arii, and Y. Katayama. 2004. Mild hypothermia enhances the neuroprotective effects of FK506 and expands its therapeutic window following transient focal ischemia in rats. Brain Res. 1008:179–185.PubMedCrossRef
25.
go back to reference del Brutto O. H. 2004. Relationship between body temperature and prognosis, and neuroprotective effect of hypothermia in acute stroke patients. Rev. Neurol. 38:1050–1055.PubMed del Brutto O. H. 2004. Relationship between body temperature and prognosis, and neuroprotective effect of hypothermia in acute stroke patients. Rev. Neurol. 38:1050–1055.PubMed
26.
go back to reference Steinberg G. K., C. S. Ogilvy, L. M. Shuer, E. S. Connolly Jr., R. A. Solomon, A. Lam, N. F. Kassell, C. J. Baker, S. L. Giannotta, K. M. Cockroft, T. E. Bell-Stephens, and R. L. Allgren. 2004. Comparison of endovascular and surface cooling during unruptured cerebral aneurysm repair. Neurosurgery 55:307–314.PubMedCrossRef Steinberg G. K., C. S. Ogilvy, L. M. Shuer, E. S. Connolly Jr., R. A. Solomon, A. Lam, N. F. Kassell, C. J. Baker, S. L. Giannotta, K. M. Cockroft, T. E. Bell-Stephens, and R. L. Allgren. 2004. Comparison of endovascular and surface cooling during unruptured cerebral aneurysm repair. Neurosurgery 55:307–314.PubMedCrossRef
27.
go back to reference Audebert H. J., M. M. Rott, T. Eck, and R. L. Haberl. 2004. Systemic inflammatory response depends on initial stroke severity but is attenuated by successful thrombolysis. Stroke 35:2128–2133.PubMedCrossRef Audebert H. J., M. M. Rott, T. Eck, and R. L. Haberl. 2004. Systemic inflammatory response depends on initial stroke severity but is attenuated by successful thrombolysis. Stroke 35:2128–2133.PubMedCrossRef
28.
go back to reference De Georgia M. A., D. W. Krieger, A. bou-Chebl, T. G. Devlin, M. Jauss, S. M. Davis, W. J. Koroshetz, G. Rordorf, and S. Warach. 2004. Cooling for Acute Ischemic Brain Damage. COOL AID.: a feasibility trial of endovascular cooling. Neurology 63:312–317.PubMed De Georgia M. A., D. W. Krieger, A. bou-Chebl, T. G. Devlin, M. Jauss, S. M. Davis, W. J. Koroshetz, G. Rordorf, and S. Warach. 2004. Cooling for Acute Ischemic Brain Damage. COOL AID.: a feasibility trial of endovascular cooling. Neurology 63:312–317.PubMed
29.
go back to reference van Breda E. J., H. B. van der Worp, H. M. van Gemert, A. Algra, L. J. Kappelle, J. van Gijn, P. J. Koudstaal, and D. W. Dippel. 2004. Reduction of body temperature with paracetamol in patients with acute stroke: randomised clinical trials are needed. Cerebrovasc. Dis. 18:350.PubMedCrossRef van Breda E. J., H. B. van der Worp, H. M. van Gemert, A. Algra, L. J. Kappelle, J. van Gijn, P. J. Koudstaal, and D. W. Dippel. 2004. Reduction of body temperature with paracetamol in patients with acute stroke: randomised clinical trials are needed. Cerebrovasc. Dis. 18:350.PubMedCrossRef
30.
go back to reference Slotboom J., C. Kiefer, C. Brekenfeld, C. Ozdoba, L. Remonda, K. Nedeltchev, M. Arnold, H. Mattle, and G. Schroth. 2004. Locally induced hypothermia for treatment of acute ischaemic stroke: a physical feasibility study. Neuroradiology 46:923–934.PubMedCrossRef Slotboom J., C. Kiefer, C. Brekenfeld, C. Ozdoba, L. Remonda, K. Nedeltchev, M. Arnold, H. Mattle, and G. Schroth. 2004. Locally induced hypothermia for treatment of acute ischaemic stroke: a physical feasibility study. Neuroradiology 46:923–934.PubMedCrossRef
31.
go back to reference Coller B. S., 2005. Leukocytosis and ischemic vascular disease morbidity and mortality: is it time to intervene? Arterioscler. Thromb. Vasc. Biol. 25:658–670.PubMedCrossRef Coller B. S., 2005. Leukocytosis and ischemic vascular disease morbidity and mortality: is it time to intervene? Arterioscler. Thromb. Vasc. Biol. 25:658–670.PubMedCrossRef
32.
go back to reference Erikssen G., K. Liestol, J. V. Bjornholt, H. Stormorken, E. Thaulow, and J. Erikssen. 2000. Erythrocyte sedimentation rate: a possible marker of atherosclerosis and a strong predictor of coronary heart disease and mortality. Eur. Heart. J. 21:1614–1620.PubMedCrossRef Erikssen G., K. Liestol, J. V. Bjornholt, H. Stormorken, E. Thaulow, and J. Erikssen. 2000. Erythrocyte sedimentation rate: a possible marker of atherosclerosis and a strong predictor of coronary heart disease and mortality. Eur. Heart. J. 21:1614–1620.PubMedCrossRef
33.
go back to reference Maresca G., A. Di Blasio, R. Marchioli, and G. Di Minno. 1999. Measuring plasma fibrinogen to predict stroke and myocardial infarction: an update. Arterioscler. Thromb. Vasc. Biol. 19:1368–1377.PubMed Maresca G., A. Di Blasio, R. Marchioli, and G. Di Minno. 1999. Measuring plasma fibrinogen to predict stroke and myocardial infarction: an update. Arterioscler. Thromb. Vasc. Biol. 19:1368–1377.PubMed
34.
go back to reference Labarrere C. A., and G. P. Zaloga. 2004. C-reactive protein: from innocent bystander to pivotal mediator of atherosclerosis. Am. J. Med. 117:499–507.PubMedCrossRef Labarrere C. A., and G. P. Zaloga. 2004. C-reactive protein: from innocent bystander to pivotal mediator of atherosclerosis. Am. J. Med. 117:499–507.PubMedCrossRef
Metadata
Title
Oral Temperature in Daily Life. A New Look in the Era of Microinflammation
Authors
O. Rogowski
I. Shapira
S. Toker
A. Shirom
S. Melamed
S. Berliner
Publication date
01-06-2005
Published in
Inflammation / Issue 2-3/2005
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-006-9006-y

Other articles of this Issue 2-3/2005

Inflammation 2-3/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.